Change Agents Corporation (CHGA) AI Stock Analysis
CHGA AI stock analysis summary
AI ResearchChange Agents Corporation (CHGA) is a micro-cap company focused on artificial intelligence platforms and consumer health technology. The company generated $0 in trailing twelve month revenue with a current ratio of 0.11 and cash of $39,221 as of June 30, 2026. Its stock has declined 96.5% over the past year to a market capitalization of $1.8M.
- Market cap
- $1.8M
- Revenue (TTM)
- $0
- P/E
- 0.8x
- 1Y return
- -96.5% S&P 500 16.8%
- Avg. target
- —
Bull case
- The company reported a positive trailing twelve month EPS of $2.00 for the period ending June 30, 2026.
- The stock trades at a trailing price-to-earnings ratio of 0.8x, well below the 21.6x median of its US-listed Real Estate peers.
- Insiders maintain a significant alignment of interest, holding 31.3% of the company's outstanding shares.
Bear case
- Liquidity is severely constrained, with cash and short-term investments of only $39,221 against total debt of $1.3M as of June 30, 2026.
- Revenue declined to -$846,588 in FY2024 and totaled $0 over the trailing twelve months ended June 30, 2026.
- The five-year share count increased by 54925.8% through FY2025, reflecting extreme equity dilution.
What Change Agents does
Change Agents Corporation, formerly known as Avalon GloboCare Corp. until July 2026, develops artificial intelligence platforms across the United States and China. The company operates through two segments: Consumer Health Technology and Artificial Intelligence Content Technology. Its offerings include automated video generation, enterprise documentation, workflow automation solutions, cellular therapy, and generative AI publishing and software. In addition, the company distributes the KetoAir breathalyzer device for detecting acetone levels in exhaled breath, alongside the AI Nutritionist software program designed to assist users in managing ketogenic diet programs. Founded in 2015, the firm employs 2 people and is based in Freehold, New Jersey.
Growth and profitability
Revenue stood at $1.3M in FY2021 before falling 9.6% to $1.2M in FY2022. Sales rose 4.5% in FY2023 to $1.3M, but dropped 167.4% in FY2024 to -$846,588. Operating margins were negative across earlier years, recording -663.9% in FY2021, -619.1% in FY2022, and -572.0% in FY2023, before registering 571.9% in FY2024. Net income was -$9.1M in FY2021, -$11.9M in FY2022, -$16.7M in FY2023, and -$7.9M in FY2024. For the trailing twelve months ending June 30, 2026, the company recorded $0 in revenue, with a profit margin of 0.0% and an operating margin of 0.0%, while diluted EPS was $2.00.
Balance sheet and cash flow
As of the quarter ended June 30, 2026, Change Agents Corporation held $39,221 in cash and short-term investments against total debt of $1.3M, resulting in net debt of $1.3M. Total assets stood at $14.7M and shareholders' equity was $10.1M, yielding a current ratio of 0.11 and a debt-to-equity ratio of 0.13. Cash generation has been constrained, with free cash flow of -$5.0M in FY2021, -$16.0M in FY2022, -$6.5M in FY2023, and -$5.0M in FY2024. Over the five-year period through FY2025, the company's share count increased 54925.8%.
Valuation and performance
Change Agents Corporation trades at a trailing price-to-earnings ratio of 0.8x and an enterprise-value-to-revenue multiple of 17.0x, compared to a trailing P/E of 21.6x and a price-to-sales ratio of 3.7x for the median of its US-listed Real Estate peers. Its price-to-book ratio is 7.5x, alongside a market capitalization of $1.8M and an enterprise value of $21.1M. Over the past year, CHGA stock has dropped 96.5%, underperforming the S&P 500 benchmark ETF return of 16.8%. Over a five-year period, the stock fell 99.9% while the benchmark gained 83.0%.
What analysts expect
Change Agents Corporation has its next earnings date scheduled for November 13, 2026. Wall Street consensus rating counts, average price targets, and forward earnings estimates are not published for the company. Historical earnings per share ranged from -$321.35 in FY2021 to -$678.93 in FY2024, before reaching trailing twelve month earnings per share of $2.00 as of the quarter ended June 30, 2026.
Key risks and what to watch
- The company's current ratio stands at 0.11, indicating acute difficulty in meeting short-term obligations.
- Free cash flow has been persistently negative, recording -$5.0M in FY2024 and -$16.0M in FY2022.
- The stock exhibits extreme downward momentum, falling 93.5% year-to-date and trading 82.3% below its 200-day moving average.
- Short interest represents 10.4% of float, highlighting notable market skepticism around business viability.
AI-generated research summary. Written with AI from Quotelinks data as of October 16, 2026 and checked so every figure matches that data. For information only, not investment advice. Disclaimer
About this CHGA AI stock analysis
This page is an AI-written research summary of Change Agents Corporation (CHGA). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.
Related: CHGA income statement, CHGA balance sheet, CHGA key metrics, CHGA chart. See the CHGA stock overview for the latest quote and news.
CHGA AI stock analysis FAQ
What does Change Agents Corporation do?
Change Agents Corporation develops artificial intelligence platforms for video generation, enterprise documentation, and workflow automation in the United States and China. It also commercializes healthcare technology, including the KetoAir breathalyzer and the AI Nutritionist software program.
What is CHGA's cash position and debt level?
As of June 30, 2026, the company held $39,221 in cash and short-term investments alongside total debt of $1.3M. This gives the company net debt of $1.3M and a current ratio of 0.11.
Does Change Agents Corporation pay a dividend?
No, Change Agents Corporation does not pay a dividend.
How has CHGA stock performed compared to the broader market?
CHGA stock fell 96.5% over the past year and 99.9% over five years as of October 16, 2026. In comparison, the S&P 500 ETF (SPY) gained 16.8% over the past year and 83.0% over five years.
When does Change Agents Corporation report earnings next?
The company's next earnings report is scheduled for November 13, 2026.